Latest filing published 13 Apr 2018 for IRLAB Therapeutics, €12k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anders Vedin: trading record in brief
All filings by Anders Vedin on record concern IRLAB Therapeutics. Over a trading history stretching from 16 May 2017 to 13 April 2018, the count stands at 4 filings.
Purchases make up the whole of the open-market record (4 purchases, €32k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2018 to date brings 3 purchases and no sales.
Half of the purchases are above €9,754 and half below. No cluster: in 4 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 13 April 2018, reports an open-market purchase of €12k in IRLAB Therapeutics. Most trades are made public on the day they happen. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Anders Vedin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ SEK 120.2035.8% of flowISIN SE0009242225FI:csv-3fd98fa61eb652c4d311Canonical exit: 12 Jul 2018 (T+90)
- 96 shares@ SEK 127.5123.8% of flowISIN SE0009242225FI:csv-6ea2ffe0ebac55a41501Canonical exit: 24 Apr 2018 (T+90)
- 704 shares@ SEK 126.7328.0% of flowISIN SE0009242225FI:csv-303ec2e9cb654a622331Canonical exit: 24 Apr 2018 (T+90)
- 2,000 shares@ SEK 50.9032.3% of flowISIN SE0009242225FI:csv-47b03bb0ed48184ae358Canonical exit: 14 Aug 2017 (T+90)
4 of 4 declarations